MENS
Jyong Biotech Ltd. Ordinary Shares
NASDAQ: MENS · HEALTHCARE · BIOTECHNOLOGY
$2.18
+0.46% today
Updated 2026-04-29
Market cap
$164.98M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.04
Dividend yield
—
52W range
$1 – $67
Volume
0.2M
Jyong Biotech Ltd. Ordinary Shares (MENS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — |
| Cost of revenue | — | $121000.00 | $122000.00 | $127000.00 | $120000.00 |
| Gross profit | — | $-121000.00 | $-122000.00 | $-127000.00 | $-120000.00 |
| Gross margin | — | — | — | — | — |
| R&D | $1.51M | $1.56M | $1.29M | $1.07M | $927000.00 |
| SG&A | $859000.00 | $791000.00 | $1.49M | $1.68M | $1.08M |
| Operating income | $-2.45M | $-2.40M | $-2.83M | $-2.80M | $-2.06M |
| Operating margin | — | — | — | — | — |
| EBITDA | $-2.34M | $-3.24M | $-5.74M | $-3.52M | $-1.86M |
| EBITDA margin | — | — | — | — | — |
| EBIT | $-2.45M | $-3.36M | $-5.87M | $-3.64M | $-1.98M |
| Interest expense | $832000.00 | $835000.00 | $765000.00 | $757000.00 | $1.03M |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.92M | $-4.20M | $-6.63M | $-4.40M | $-3.02M |
| Net income growth (YoY) | — | -119.1% | -57.9% | +33.6% | +31.4% |
| Profit margin | — | — | — | — | — |